In the future, HIV/AIDS may be the single most important factor ... This has left many patients with no choice but to live with the virus or resort to obtaining drugs in the black market.

18, 2025 — Viruses, like those that cause COVID-19 or HIV ... infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus ...

Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a ...

A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s ...

There’s no cure yet for HIV or stage 3 HIV, also known as AIDS. However ... HIV uses to put HIV DNA into human DNA inside the CD4 T cells. INSTIs belong to a category of drugs known as integrase ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...

What Are HIV/AIDS Medications? HIV medications can ... It blocks a specific kind of "hook" on the outside of certain cells so the virus can't plug in. Because these "drug boosters" can raise ...

Antiretroviral therapy (ART) can keep HIV suppressed indefinitely, but the virus inserts its genetic blueprints into host cells and establishes a long-lasting reservoir that is nearly impossible to ...

The study found 20% of women who took a drug intervention that included antibodies remained virally suppressed without ...

The number of people living with HIV in South Africa continues to rise, surpassing eight million in 2024. This is according ...